NanoTess
NanoTess
NanoTess
NanoTess
NanoTess
NanoTess

Science With Soul: Where Compassion Meets Innovation

Medical Device & Emerging Tech

NanoSALV Catalytic works alongside the body’s cellular response to injury, inflammation, or infection.

‍

Healthy healing requires our bodies to execute a carefully coordinated set of processes and events at the cellular level, with sufficient chemical energy to initiate each subsequent biochemical and cellular step. 
‍

This coordination is often disrupted by aging, illness, or comorbidities, preventing the body from progressing efficiently through the healing cascade: Hemostasis, Inflammation, Proliferation, and Remodeling.

‍

For example, activated platelets release PDGF, TGF-β, PAF, and extracellular matrix proteins such as fibronectin, initiating early wound repair signaling. Injured endothelial cells and resident immune cells subsequently produce prostaglandins, chemokines, and pro-inflammatory cytokines that amplify the inflammatory response. Neutrophils provide early antimicrobial defense, and macrophages clear debris and bacteria while releasing growth factors that stimulate fibroblast-mediated extracellular matrix synthesis, enabling the formation of new healthy tissue.
‍

NanoSALV Catalytic Treatment Matrix

  • Actively promotes and optimizes healing
  • Modulates inflammation by enabling the body’s natural healing progression and copper-dependent cellular signaling, serving as a first-line therapy option before escalating to topical steroids
  • Provides long-lasting, broad-spectrum antimicrobial effects while remaining biocompatible
NanoSALV Catalytic Treatment Matrix

57% faster healing, proven in clinical trials

The result is 57% faster healing times; proven in clinical trials and demonstrated in the lives of thousands of patients across Canada.

Because all this work is done by catalysts at a micron scale, working alongside the body’s natural biology and not metabolized by the body - unlike drugs - NanoSALV Catalytic is classed as a medical device. NanoSALV Catalytic offers a high safety profile with ingredients that the body naturally recognizes and processes, offering inherent biocompatibility. NanoSALV Catalytic’s physiology-aligned design ensures it has no duration of use limitations or age-related contraindications, integrating seamlessly into standard skin and wound-care practices.

NanoSALV Catalytic is now covered under Alberta Public Programs and Private Wellness Spending Plans. Pseudo-DIN: 00999688

57% faster healing, proven in clinical trials

Proven to heal wounds 57% faster¹ and reduce wound care costs by 46%²

Injured. Inflamed. Infected. Prescribe NanoSALV Catalytic.

¹W21C Research and Innovation. Centre Act to Improve Pressure Injuries in Alberta: Feasibility of Using NanoSALV Catalytic Advanced Wound Care Treatment Matrix to Treat Pressure Injuries and Chronic Wounds. 2023. ²Institute of Health Economics, Executive Summary - Trial-based Economic Evaluation for the NanoSALV Catalytic Advanced Wound Care Treatment Matrix for the Management of Pressure Injuries, Diabetic Foot Ulcers, and Leg Ulcers, Table 5. Nov 2023.

Proven to heal wounds 57% faster¹ and reduce wound care costs by 46%²

What people are saying

No items found.

Explore More Partners

Explore the Hub

Join our Newsletter

Get new healthcare roles and hiring insights in your inbox. No spam, unsubscribe anytime.